page_banner

67630-00-6 Tert-butoxycarbonyl-4-NO2-fenylalanine-estyl ester

67630-00-6 Tert-butoxycarbonyl-4-NO2-fenylalanine-estyl ester

Ibisobanuro bigufi:

Kugaragara Umweru Kuri Off-Yera ya kirisiti cyangwa ifu ya kristaline.
MF C16H22N2O6
MW 338.36
Isuku 98+


Ibicuruzwa birambuye

Imiterere yubwikorezi & uburyo bwo kohereza:
n'ikirere, ku nyanja cyangwa muri Express

Imiterere y'ububiko:
Ikidodo cyumye, Ubushyuhe bwicyumba

Ibicuruzwa ntarengwa Qty:
Ibiganiro

Icyemezo:
COA, HPLC, GC, HNMR, Isuzuma, Ibirimo Amazi (KF), TLC irahari

D-Lys (tfa) -NCA (2)

Synonyme

(S) -ethyl 2- (tert-butoxycarbonylaMino) -3- (4-nitrophenyl) propanoate;
Boc- (4-NO2) -L-Phe-OEt;
Boc- (4-NO2) -Oet;
Boc-Phe (4-NO2) -Oet;
L-Phenylalanine;
N - [(1,1-dimethylethoxy) karubone] -4-nitro-, estyl ester

Gupakira imbere

Mubisanzwe bikoreshwa mugupakira ifu.Kandi zirashobora kubuza izuba n'amazi kuba bibi.

Gupakira imbere 2
Gupakira imbere 1
Gupakira imbere 3

gupakira hanze

Ikarito ikomeye irashobora kurinda ibicuruzwa byawe kugwa no gutose.

Gupakira hanze 3
Gupakira hanze 2
Gupakira hanze 1

Porogaramu

Nidanib, ni imiti.Izina ryimiti 1 h - indole - 6 - acide karubike, 2, 3 - dihydro - 3 - [[[4 - (methyl - 2 - ogisijeni -, methyl ester, (z) - Mu ivuriro, iki gicuruzwa gikoreshwa mu kuvura indwara ya fibrosis idasanzwe (IPF).
Nidanib yakoze ubushakashatsi ku barwayi 1.529 barwaye fibrosis idasanzwe (IPF) mu bigeragezo byinshi by’amavuriro.Amakuru yumutekano yatanzwe ashingiye ku kugereranya abarwayi 1061 bahawe nidanib 150 mg kabiri kumunsi na placebo mubyiciro bibiri byicyumweru 52 icyiciro cya 3, batabishaka, impumyi ebyiri, ubushakashatsi bugenzurwa na placebo (INPULSIS-1 na INPULSIS-2).Ibintu bibi byakunze kugaragara bifitanye isano no gukoresha nidanib harimo impiswi, isesemi no kuruka, kubabara mu nda, kubura ubushake bwo kurya, guta ibiro, hamwe na enzymes zumwijima.Nyamuneka reba kuri [Precautions] kugirango ucunge ibisubizo bibi.Itondekanya rya Organisation Itunganijwe (SOC) ya MedDRA itanga incamake yimyitwarire mibi no gutondekanya inshuro.
Nidanib ni substrate ya P-gp (reba Pharmacokinetics).Mu bushakashatsi bwihariye bwerekeye imikoranire yibiyobyabwenge, hamwe hamwe nubuyobozi bwa ketoconazole, imbaraga za P-gp inhibitor, byongereye guhura nidanib inshuro 1.61 kubice biri munsi yumurongo (AUC) ninshuro 1.83 hamwe nubushakashatsi bwimbitse (Cmax).
Mu bushakashatsi bwakozwe ku biyobyabwenge hamwe na P-gp inducer rifampicin ikomeye, guhura na nidanib byagabanutse kugera kuri 50.3%, nkuko byapimwe n'akarere kari munsi y'umurongo (AUC), iyo bihujwe na rifampicine ugereranije na Nidanib wenyine.Kwibanda cyane (Cmax), byagabanutse kugera kuri 60.3%.
Iyo bikozwe hamwe nibicuruzwa, imbaraga za P-gp inhibitor (urugero, ketoconazole cyangwa erythromycine) irashobora kongera guhura na nidanib.Muri ibi bihe, kwihanganira umurwayi kuri nidanib bigomba gukurikiranirwa hafi.Imicungire yimyitwarire mibi irashobora gusaba guhagarika, kugabanya imiti, cyangwa guhagarika imiti hamwe niki gicuruzwa (reba [Ikoreshwa na dosiye]).
P-gp inducers zikomeye (urugero, rifampicin, karbamazepine, phenytoin na wort ya Mutagatifu Yohani) irashobora kugabanya guhura na nidanib.Ubundi buryo bwo guhuza hamwe nta na P-gp induction igomba kwitabwaho.

ibicuruzwa bifitanye isano

Gly-Phe Boc-Phe-Gly-Ome HN-Me-L-Phe.Hcl Boc-D-Phe-D-Phe
Boc-D-4-Chloropheny (alanine) Fmoc-L-Phe-OH L-Phe-NH2.Hcl Boc-Phe-Gly
L-Ala-Phe-OH Fmoc-D-Phe-OH 4-NO2-Phe-Oet Boc-L-Phe-Onp
Boc-Ala-Phe-OH Fmoc-N-Me-L-Phe-OH 4-NO2-Phe-Oet.HCl Boc-L-Phe-Oet
Boc-Ala-Phe-OH FMOC-N-Me-D-Phe-OH HD-Phe-OMe · HCl Boc-4-NO2-D-Phe-OEt
Fmoc-β-Ala-D-phe Fmoc-Phe-Cl HL-Phe-OMe.HCl Boc-D, L-Phe (4-NO2) -OH
Leu-Phe.Hcl Fmoc-Phe (4-NO2) -OH H-DL-Phe-OBzl .tos Fmoc-Phe-Phe-OH
Boc-Leu-Phe Cbz-L-Phe-OH H-DL-Phe (4-NO2) -OH.H2O Fmoc-Phe-Gly-OH
Cbz-L-Phe-Leu-OH Cbz-D-Phe-OH HL-Phe-OBzl.HCl Fmoc-D-Phe (4-NO2) -OH
L-Phe Cbz-DL-Phe-OH HL-Phe-OEt.HCl Cbz-Phe-Arg-OH
HD-Phe-OH Cbz-D-Phe-OL L-Phe-NH2 Cbz-Phe-Ala-OH
L-Phe-NCA ZN-Me-L-Phe-OH D-Phe-NH2 Cbz-Phe-Gly-OH
Tos-Phe cbz-L-Phe-OSU N-Ac-L-Phe-OH Cbz-Phe-Met-OH
L-Phe-ol Phe-Ala N-AC-L-Phe-Ome Cbz-Phe-Gly-Oet
L-Phe (4-NO2) -OH L-Phe-Phe N-Pht-Phe-OH Boc-Phe-Gly-Gly-OH
L-Phe (4-NO2) .H2O L-Phe-Trp Boc-Phe-OH Fmoc-L-Thr (tBu) -Phe-OH
D-Phe (4-NO2) -OH.h2o L-Phe-Leu-OH Boc-D-Phe-OH D-Phe-NH2
D-Phe (4-NO2) -OH L-Phe-Tyr-OH Boc-DL-Phe-OH Tyr-Phe
N-Me-D-Phe L-Phe-Gly BOC-N-Me-D-Phe-OH DL-Phe-Ome.Hcl
HN-Me-L-Phe-OH D-Phe-D-Phe Boc-N-Me-DL-Phe-OH Boc-Met-Leu-Phe
L-Phe.hcl L-Phe-OBzl-OH Boc-N-Me-L-Phe-OH Asp-Phe-Ome
4-NO2-D-phe.hcl D-Phe-Obzl.Tos Boc-N-Me-L-Phe-OH.DCHA L-Homophe-OH
HL-Phe-OtBu.HCl Boc-Phe-Ala-OH Boc-DN-Me-Phe • DCHA D-Homophe-OH
HD-Phe-OtBu.HCl Boc-Phe-Leu-OH Boc-Phe-Ol L-Homophe-Oet.Hcl
D, L-Phe-OtBu HCl Boc-Phe-Trp-OH Boc-D-Phe-Ol D-Homophe-Oet.HCl
HD-Phe (4-NO2) -Ome.HCl Boc-L-Phe-Tyr-OH Boc-Phe-NH2 Boc-L-Homophe-OH
D-Phe-Obzl.Hcl Boc-Phe-Phe-OH Boc-L-Phe-Ome Boc-D-Homophe-OH
DL-Phe-Ome.Hcl Boc-D-Phe-Phe Boc-D-Phe-Ome Fmoc-L-HomoPhe-OH
Boc-D-Phe (4-NO2) -OH Cbz-D-Homophe-OH Boc-Phe-Obzl Fmoc-D-Homophe-OH
Boc-L-Phe-OSU Boc-Homophe-Leu-Phe-Ome Boc-4-NO2-Phe-OH Cbz-L-Homophe-OH
Boc-D-Phe-OSU      

Ubukuru

1. Serivisi ya R&D irahari
2. ISO yemewe, ingwate nziza
3.Isomo ryuzuye rya serivisi yo gukurikirana mugihe cyo gukora
4.Igiciro kinini
5.Inyandiko zemeza ubuziranenge zitangwa kubisabwa umukiriya
6.Ibikorwa byiza nyuma yo kugurisha, gukomeza umubano wa hafi nabakiriya
7.Umutungo wuzuye kugirango ufashe kugabanya ibiciro byo kohereza
8.Urugero rwubusa rutangwa kugirango ugenzure ubuziranenge mbere yo kwishyura
9. Igihe cyo kwishyura cyumvikanyweho
10.Kwemerera abakiriya gukemura ibibazo mubushinwa


  • Mbere:
  • Ibikurikira:

  • Andika ubutumwa bwawe hano hanyuma utwohereze